Erratum to: Efficacy and Tolerability of Once-Daily Grepafloxacin Compared with Clarithromycin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis

C. Andrew DeAbate,Douglas Myers,Dan C. Henry,John Upchurch,Grace Lecara,Gregory Giguere,Jeffrey J. Collins

Erratum to: Efficacy and Tolerability of Once-Daily Grepafloxacin Compared with Clarithromycin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis

1999

C. Andrew DeAbate
Douglas Myers
Dan C. Henry
John Upchurch
Grace Lecara
Gregory Giguere
Jeffrey J. Collins

Objectives: The clinical and bacteriological efficacies and tolerability of grepafloxacin 400mg once daily for 10 days were compared with clarithromycin 500mg twice daily for 10 days in patients with acute bacterial exacerbations of chronic bronchitis (ABECB).

Keywords:

Bronchitis
Grepafloxacin
Moraxella catarrhalis
Medicine
Clarithromycin
Tolerability
Anesthesia
Diabetes mellitus
Internal medicine
once daily
chronic bronchitis
Pharmacotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations